Study Overview Study Details Eligibility Trial Primary Objective:To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)Secondary Objectives:To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivationTo continue to …
This is a phase2, randomized, double-blind, multi-center, multi-dose and placebo parallel controlled design. The subjects in the study group were given double-blind drugs, and they were taken (orally) after dinner every day according to the requirements of clinical trial scheme.
Congrats! You have your own personal workspace now.